Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Wearable Injectors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Wearable Injectors was estimated at US$10.7 Billion in 2023 and is projected to reach US$20.4 Billion by 2030, growing at a CAGR of 9.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players in the Wearable Injectors market such as Amgen, Inc., Becton, Dickinson and Company, Bespak Europe Ltd., Enable Injections, Inc., Insulet Corporation and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Factors Driving the Growth of the Global Wearable Injectors Market
The growth in the global wearable injectors market is driven by several factors, including advancements in drug delivery technology, the increasing prevalence of chronic diseases, and the rising adoption of home healthcare. One of the primary growth drivers is the rising demand for biologic therapies, which are used to treat a wide range of conditions, including autoimmune diseases, cancer, and hormonal disorders. Biologic drugs are often administered in high volumes or require prolonged infusion times, making them ideal candidates for delivery via wearable injectors. The expanding pipeline of biologic drugs, coupled with the increasing number of patients receiving these therapies, has created a significant market opportunity for wearable injectors that can deliver these complex drugs safely and effectively. Pharmaceutical companies are increasingly adopting wearable injectors as part of their drug delivery strategies, particularly for therapies that require patient adherence and long-term management.
Another key growth driver is the increasing focus on improving patient adherence and compliance with therapy. Poor adherence to injectable therapies is a major challenge in chronic disease management, leading to suboptimal treatment outcomes and increased healthcare costs. Wearable injectors address this challenge by providing a more convenient and less invasive method of drug delivery, reducing the frequency and discomfort associated with traditional injections. The ability of wearable injectors to deliver drugs over an extended period also reduces the need for multiple injections, making it easier for patients to adhere to their prescribed regimens. The integration of smart technology and connectivity features in wearable injectors has further enhanced their ability to support patient adherence by providing reminders, monitoring dosing history, and facilitating communication with healthcare providers.
The global wearable injectors market is also benefiting from the increasing trend towards home-based healthcare and the expansion of telemedicine services. As healthcare systems strive to reduce hospital admissions and provide care closer to home, wearable injectors are becoming a key enabler of remote patient management. These devices allow patients to receive complex therapies without the need for in-person visits, supporting the growing demand for home infusion services and telehealth solutions. Moreover, the rising geriatric population, which is more susceptible to chronic diseases and complex medication regimens, is expected to drive further growth in the wearable injectors market. As the technology continues to evolve and the range of therapies administered via wearable injectors expands, the global market is poised for sustained growth, driven by a dynamic interplay of innovation, patient demand, and evolving healthcare practices.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the On-Body injectors segment, which is expected to reach US$14.7 Billion by 2030 with a CAGR of a 9.4%. The Off-Body injectors segment is also set to grow at 10.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, which was estimated at $2.9 Billion in 2023, and China, forecasted to grow at an impressive 9% CAGR to reach $3.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Some of the 43 companies featured in this Wearable Injectors market report include:
- Amgen, Inc.
- Becton, Dickinson and Company
- Bespak Europe Ltd.
- Enable Injections, Inc.
- Insulet Corporation
- Medtronic PLC
- Sensile Medical AG
- Tandem Diabetes Care, Inc.
- United Therapeutics Corporation
- Valeritas, Inc.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 193 |
| Forecast Period | 2023-2030 |
| Estimated Market Value (USD) in 2023 | $10.7 Billion |
| Forecasted Market Value (USD) by 2030 | $20.4 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Wearable Injectors - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Demand for Self-Administration and Home-Based Drug Delivery Solutions Drives Growth of Wearable Injectors Market
- Increased Adoption of Wearable Injectors in Chronic Disease Management Expands Addressable Market
- Surge in Demand for Wearable Injectors in Diabetes and Insulin Delivery Fuels Market Growth
- Rising Adoption of Wearable Injectors in Oncology and Biologic Drug Delivery Sets the Stage for Market Growth
- Surge in Use of Wearable Injectors in Hormone and Pain Management Therapies Expands Market Opportunities
- Technological Innovations in Micro-Needle and Patch-Based Wearable Injectors Propel Market Growth
- Increased Utilization of Wearable Injectors in Rheumatology and Immunology Drug Delivery Fuels Market Demand
- Rising Focus on Reducing Hospital Visits and Healthcare Costs Drives Adoption of Wearable Injectors
- Surge in Demand for Wearable Injectors in Cardiology and Endocrinology Applications Expands Market Opportunities
For more information about this report visit https://www.researchandmarkets.com/r/fvzbu0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
